TY - JOUR
T1 - Functionalization of Nanomaterials and Their Application in Melanoma Cancer Theranostics
AU - Madamsetty, Vijay Sagar
AU - Paul, Manash K.
AU - Mukherjee, Anubhab
AU - Mukherjee, Sudip
N1 - Publisher Copyright:
© 2019 American Chemical Society.
PY - 2020/1/13
Y1 - 2020/1/13
N2 - Treatment and cure for melanoma, the most aggressive subcategory of skin cancer, still remains a daunting challenge to be circumvented. When metastasized, it requires radiotherapy, chemotherapy, targeted therapy, immunotherapy, etc. as its treatment, although it can be removed by surgical intervention if detected in its early stage. Development of upgraded therapeutic modalities for melanoma facilitating early diagnosis with subsequent excision before metastasis is, therefore, an urgent need. As we witnessed, nanotechnology has become instrumental with its far-reaching ramifications both in diagnosis and treatment of melanoma. In this review we are going to summarize the encouraging developments made in recent times for functionalization of nanoparticles (including liposomes, polymeric, metal, viral, protein nanoparticles) to create numerous theranostics (therapy plus diagnostics) for melanoma. We will also reflect on the melanoma statistics, molecular biology, conventional therapies, ongoing clinical trials, and future outlook.
AB - Treatment and cure for melanoma, the most aggressive subcategory of skin cancer, still remains a daunting challenge to be circumvented. When metastasized, it requires radiotherapy, chemotherapy, targeted therapy, immunotherapy, etc. as its treatment, although it can be removed by surgical intervention if detected in its early stage. Development of upgraded therapeutic modalities for melanoma facilitating early diagnosis with subsequent excision before metastasis is, therefore, an urgent need. As we witnessed, nanotechnology has become instrumental with its far-reaching ramifications both in diagnosis and treatment of melanoma. In this review we are going to summarize the encouraging developments made in recent times for functionalization of nanoparticles (including liposomes, polymeric, metal, viral, protein nanoparticles) to create numerous theranostics (therapy plus diagnostics) for melanoma. We will also reflect on the melanoma statistics, molecular biology, conventional therapies, ongoing clinical trials, and future outlook.
UR - https://www.scopus.com/pages/publications/85076304334
UR - https://www.scopus.com/pages/publications/85076304334#tab=citedBy
U2 - 10.1021/acsbiomaterials.9b01426
DO - 10.1021/acsbiomaterials.9b01426
M3 - Article
C2 - 33463233
AN - SCOPUS:85076304334
SN - 2373-9878
VL - 6
SP - 167
EP - 181
JO - ACS Biomaterials Science and Engineering
JF - ACS Biomaterials Science and Engineering
IS - 1
ER -